entertainment -WSS

entertainment

author：Wikipedia 2025-08-25 05:56:57 - browse：97782

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of expert advisers to the Food and Drug Administration on Friday voted in favor of expanding the use of CAR-T therapy in blood cancer, despite concerns about the powerful treatment’s side effects.

The group voted 11-0 that the benefits of Carvykti, a CAR-T medicine from Johnson & Johnson and Legend Biotech, outweighed its risk for patients with multiple myeloma whose disease has persisted despite initial treatment. The same panel voted 8-3 in favor of Abecma, from Bristol Myers Squibb and 2seventy Bio, for multiple myeloma patients who’ve received at least two lines of therapy. Currently both medicines are approved only for patients who have been treated for myeloma with four or more medications.

In clinical trials, each drug proved to significantly delay disease progression compared to standard therapy. But zooming in on the data, the FDA observed an alarming imbalance of deaths in the early months of both studies, finding that more patients in the CAR-T group died of myeloma or side effects than those receiving the standard of care.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Dementia risk linked to living in disadvantaged areas: Study

WSS

Diversity in medical illustrations gets boost from Chidiebere Ibe

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

How Long Island became the ‘eugenics capital of the world’

2024 GOP presidential candidates spar over abortion in debate

Radiation, mainstay of cancer treatment, begins a fade

How to make AI work for medicine

focus

entertainment

entertainment

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

AstraZeneca bets AAV gene therapy will still deliver the goods

Jerome Adams on the need for new antivirals for Covid

Study finds new variant for Parkinson’s in African populations

Medicare proposal to cover medical devices draws a mixed reaction

Study finds new variant for Parkinson’s in African populations

Psychedelics group wrestles with new pharma identity

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Activists slam private health insurers over coverage restrictions

Mystery swirls around US soldier who entered North Korea days ago, officials say

focus

Stanford president’s abrupt resignation sparks debate

Caribou posts encouraging results on off

Diversity in medical illustrations gets boost from Chidiebere Ibe

CDC advisory panel says seniors 'may' get RSV vaccine

Neuroscience startup Neumora files for IPO

Delta passengers in Vegas fall sick while waiting on flight in triple

hotspot

focus

leisure time

focus